Stocksigma LogoStocksigma Logo

Caplin Point Subsidiary Receives GMP Certification from Colombia's INVIMA

Caplin Point Laboratories announced on Sep 01, '26 that its subsidiary, Caplin One Labs (COL), received Good Manufacturing Practices (GMP) compliance

Caplin Point Subsidiary Receives GMP Certification from Colombia's INVIMA

Caplin Point Laboratories Ltd 路 Others (Uncategorized) 路 01 Sept 2026, 11:34 pm

Caplin Point Subsidiary Receives GMP Certification from Colombia's INVIMA Caplin Point Laboratories announced on Sep 01, '26 that its subsidiary, Caplin One Labs (COL), received Good Manufacturing Practices (GMP) compliance confirmation from Colombia's regulatory authority, INVIMA. The certification is for COL's manufacturing unit in Tamil Nadu, India. It covers the production of oncology drug products, including sterile lyophilized powder for injection (vials) and non-sterile tablets and capsules. This approval is a key regulatory milestone, facilitating market access and supply of these cancer treatments to Colombia. The formal certificate is expected shortly.

Original exchange filing (PDF)

More announcements from Caplin Point Laboratories Ltd

All Caplin Point Laboratories Ltd announcements